Castleark Management LLC Cytokinetics Inc Transaction History

Castleark Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$63.75 - $108.06 $1.34 Million - $2.27 Million	20,980 New	20,980 $1.47 Million
Q1 2023 May 15, 2023	SELL	$33.36 - $45.71 $1.69 Million - $2.32 Million	-50,680 Reduced 59.41%	34,625 $1.22 Million
Q4 2022 Feb 09, 2023	SELL	$35.77 - $51.11 $2.75 Million - $3.92 Million	-76,790 Reduced 47.37%	85,305 $3.91 Million
Q3 2022 Nov 15, 2022	BUY	$38.54 - $54.52 $356,109 - $503,764	9,240 Added 6.04%	162,095 $7.85 Million
Q2 2022 Aug 16, 2022	SELL	$33.93 - $48.92 $835,356 - $1.2 Million	-24,620 Reduced 13.87%	152,855 $6.01 Million
Q1 2022 May 16, 2022	BUY	$29.74 - $46.0 $817,255 - $1.26 Million	27,480 Added 18.32%	177,475 $6.53 Million
Q4 2021 Feb 16, 2022	BUY	$34.35 - $46.38 $5.15 Million - $6.96 Million	149,995 New	149,995 $6.84 Million

409

125M

4.6M

2.43M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.6B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Castleark Management LLC, based on Form 13F filings with the SEC.

Stay updated on Castleark Management LLC with notifications on news.